Bailly C, Echepare S, Gago F, Waring M J
Laboratoire de Pharmacologie Antitumorale, Centre Oscar Lambret, Lille, France.
Anticancer Drug Des. 1999 Jun;14(3):291-303.
Footprinting experiments with DNase I provide a starting-point for investigating the molecular basis of nucleotide sequence recognition by 2QN, a bis-quinoline derivative of the quinoxaline antibiotic echinomycin produced by directed biosynthesis in Streptomyces echinatus. Using tyrT DNA molecules variously substituted with inosine and/or 2,6-diaminopurine residues it is shown that the location of the 2-amino group of purine nucleotides in the minor groove of the double helix exerts a dominant influence in determining where the antibiotic will bind, as it does for echinomycin. However, newly created binding sites in DNA molecules substituted with diaminopurine (D), all located round TpD steps, bind 2QN with so much higher affinity than the canonical CpG steps that the latter fail completely to appear as footprints in D-substituted DNA; indeed CpG sequences appear in regions of enhanced susceptibility to nuclease cleavage as do CpI steps in doubly D + I-substituted DNA. Quantitative footprinting plots confirm that sequences surrounding TpD steps bind 2QN several hundred-fold more tightly than do CpG-containing sequences, with dissociation constants of the order of 25 nM. To test the hypothesis that differences in stacking interactions between the chromophores of the drug and the DNA base pairs could account for the differences in binding affinities, models of 2QN bound to two DNA hexamers containing either a central CpG or a central TpD step were built. Calculation of the molecular electrostatic potential (MEP) of 2QN in solution using a continuum method revealed a distinctive pattern that is considered relevant to DNA binding. When the MEPs calculated for the two DNA hexamers in the complexed state were compared, substantial differences were found in the major groove and in the space between the base pairs that is occupied by the chromophores of the drug upon binding. The modelling data support the notion that electrostatic stacking interactions underlie the considerably preferred binding of echinomycin and 2QN around TpD steps rather than CpG steps.
用DNase I进行的足迹实验为研究2QN(一种由棘孢链霉菌定向生物合成产生的喹喔啉抗生素棘霉素的双喹啉衍生物)识别核苷酸序列的分子基础提供了一个起点。使用用肌苷和/或2,6 - 二氨基嘌呤残基进行不同取代的tyrT DNA分子,结果表明,嘌呤核苷酸2 - 氨基基团在双螺旋小沟中的位置对确定抗生素的结合位置起着主导作用,就像对棘霉素一样。然而,用二氨基嘌呤(D)取代的DNA分子中新产生的结合位点,均位于TpD步附近,与2QN的结合亲和力比典型的CpG步高得多,以至于后者在D取代的DNA中完全不会以足迹形式出现;实际上,CpG序列出现在核酸酶切割敏感性增强的区域,就像在双重D + I取代的DNA中的CpI步一样。定量足迹图证实,围绕TpD步的序列与2QN的结合比含CpG的序列紧密数百倍,解离常数约为25 nM。为了检验药物发色团与DNA碱基对之间堆积相互作用的差异可能解释结合亲和力差异的假设,构建了2QN与两个分别含有中心CpG或中心TpD步的DNA六聚体结合的模型。使用连续介质方法计算溶液中2QN的分子静电势(MEP),揭示了一种被认为与DNA结合相关的独特模式。当比较复合物状态下两个DNA六聚体计算出的MEP时,发现在大沟以及结合时药物发色团占据的碱基对之间的空间存在显著差异。建模数据支持这样一种观点,即静电堆积相互作用是棘霉素和2QN在TpD步而非CpG步周围优先结合的基础。